INIS
cancer
100%
drugs
91%
proteins
74%
inhibition
63%
in vitro
59%
oxygen
56%
synthesis
54%
evaluation
50%
mitochondria
48%
dna
40%
heat-shock proteins
37%
estrone
37%
pyrazoles
37%
humans
36%
design
33%
resorcinol
31%
molecules
31%
fluorescence
28%
levels
28%
compatibility
28%
pediatrics
28%
polarization
26%
screening
25%
crystal structure
24%
in vivo
23%
enzymes
23%
apoptosis
22%
structure-activity relationships
22%
data
22%
variations
21%
tumors
20%
range
20%
residues
18%
corrections
18%
errors
18%
schools
18%
esters
18%
amides
18%
benzoic acid
18%
indicators
18%
infusion
18%
antineoplastic drugs
18%
therapeutic agents
18%
glycoproteins
18%
colon
16%
genes
13%
comparative evaluations
13%
carcinomas
13%
elevation
13%
melanomas
12%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
70%
Chaperone
63%
Heat Shock Protein 90 Inhibitor
62%
4 [4 (1,4 Benzodioxan 6 Yl) 5 Methyl 1h Pyrazol 3 Yl] 6 Ethylresorcinol
53%
Pyrazole
37%
Sulfatase
37%
Estrone
37%
Reactive Oxygen Metabolite
37%
Resorcinol
29%
Heat Shock Protein 90
29%
Drug Discovery
28%
Structure Activity Relationship
23%
Sulfamate
23%
Mitochondrial DNA
21%
High-Throughput Screening
19%
Geldanamycin
19%
Furosemide
18%
Anticarcinogen
18%
Ketamine
18%
Benzoic Acid
18%
Isoxazole
18%
Carboxamide
18%
Neoplasm
18%
P-Glycoprotein
16%
Colon Carcinoma
15%
Clonidine
12%
Sedative
12%
Midazolam
12%
Morphine
12%
Adenosine Triphosphatase
12%
Adenosine Triphosphate
12%
Reduced Nicotinamide Adenine Dinucleotide (Phosphate) Dehydrogenase (Quinone)
12%
Pharmacokinetics
10%
Hydrophobicity
9%
Carcinogenesis
9%
Disease Exacerbation
9%
Binding Site
9%
IC50
9%
Tanespimycin
9%
Western Blot
8%
Clinical Trial
8%
Natural Product
8%
Melanoma
8%
Stimulant
8%
Combination Drug
7%
Propidium Iodide
6%
Clearance Mechanism
6%
Recombinant
6%
Cell Culture
6%
Table Salt
6%
Biochemistry, Genetics and Molecular Biology
Hsp90
78%
Cancer Cell
52%
Drug Efficacy
37%
Mitochondrial DNA
28%
Hsp90 Inhibitor
27%
Anticancer
23%
Geldanamycin
23%
Heat Shock Protein 90 Inhibitor
18%
Protein Crystal Structure
18%
Mitochondrion
18%
High Throughput Screening
17%
ATPase
17%
Mitochondrial Genetics
17%
Small Molecule
15%
Heat Shock Protein
14%
Crystal Structure
13%
Antineoplastic Activity
13%
P-Glycoprotein
12%
Cisplatin
10%
Gene Dosage
9%
Drug Sensitivity
9%
Colon
8%
Clinical Trial
8%
Western Blotting
8%
GI50
7%
Adenosine Triphosphate
7%
Structural Protein
6%
Drug Resistance
6%
Dideoxynucleotide Sequencing
6%
Drug Response
6%
Real-Time Polymerase Chain Reaction
6%
Mitochondrial Genome
6%
Electron Transport Chain
6%
